VRTX icon

Vertex Pharmaceuticals
VRTX

Overview Fund Activity

1,527 hedge funds and large institutions have $107B invested in Vertex Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 117 funds opening new positions, 600 increasing their positions, 603 reducing their positions, and 143 closing their positions.

Holders
1,527
Holders Change
-68
Holders Change %
-4.26%
% of All Funds
20.51%
Holding in Top 10
16
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-38.46%
% of All Funds
0.21%
New
117
Increased
600
Reduced
603
Closed
143
Calls
$716M
Puts
$374M
Net Calls
+$342M
Net Calls Change
+$167M

Top Buyers

1
Norges Bank
1
Norges Bank
Norway
$1.59B
2
Capital International Investors
2
Capital International Investors
California
$1.17B
3
Victory Capital Management
3
Victory Capital Management
Texas
$968M
4
Capital Research Global Investors
4
Capital Research Global Investors
California
$7.17B
5
Jennison Associates
5
Jennison Associates
New York
$2.74B

Top Sellers

1
Amundi
1
Amundi
France
$518M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$2.61B
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$2.85B
4
Massachusetts Financial Services
4
Massachusetts Financial Services
Massachusetts
$572M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$2.14B
Name Market Value Shares Shares
Change 		Shares
Change %
Capital World Investors
1
Capital World Investors
California
$12.8B 28,732,143 +198,835 +0.7%
Vanguard Group
2
Vanguard Group
Pennsylvania
$10.7B 23,973,777 +482,616 +2%
BlackRock
3
BlackRock
New York
$9.74B 21,871,945 +89,012 +0.4%
Capital Research Global Investors
4
Capital Research Global Investors
California
$7.17B 16,108,291 +1,571,947 +11%
State Street
5
State Street
Massachusetts
$5.24B 11,775,227 -13,430 -0.1%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$2.85B 6,406,372 -1,320,812 -17%
Jennison Associates
7
Jennison Associates
New York
$2.74B 6,151,505 +1,089,063 +22%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$2.63B 5,928,747 +166,987 +3%
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
$2.61B 5,869,361 -1,886,284 -24%
Wellington Management Group
10
Wellington Management Group
Massachusetts
$2.14B 4,813,386 -641,362 -12%
AllianceBernstein
11
AllianceBernstein
Tennessee
$1.95B 4,378,320 +424,808 +11%
Loomis, Sayles & Company
12
Loomis, Sayles & Company
Massachusetts
$1.7B 3,813,378 +65,047 +2%
Norges Bank
13
Norges Bank
Norway
$1.59B 3,580,356 +3,580,356 New
Morgan Stanley
14
Morgan Stanley
New York
$1.48B 3,331,439 -77,081 -2%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$1.41B 3,159,870 +242,643 +8%
UBS AM
16
UBS AM
Illinois
$1.37B 3,067,473 +507,997 +20%
Bank of America
17
Bank of America
North Carolina
$1.25B 2,807,617 -57,381 -2%
Northern Trust
18
Northern Trust
Illinois
$1.18B 2,658,581 +39,189 +1%
Capital International Investors
19
Capital International Investors
California
$1.17B 2,635,903 +1,986,004 +306%
Janus Henderson Group
20
Janus Henderson Group
United Kingdom
$1.17B 2,619,534 -128,403 -5%
Edgewood Management
21
Edgewood Management
Connecticut
$1.09B 2,454,947 -189,079 -7%
Ameriprise
22
Ameriprise
Minnesota
$971M 2,181,362 -54,107 -2%
Victory Capital Management
23
Victory Capital Management
Texas
$968M 2,155,164 +1,861,279 +633%
Invesco
24
Invesco
Georgia
$883M 1,984,046 +138,406 +7%
Goldman Sachs
25
Goldman Sachs
New York
$860M 1,931,760 +197,166 +11%
1
2 3 4 5